Diabetes Mellitus Clinical Trial
Official title:
Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus
Endothelial dysfunction precedes the development of cardiovascular disease and it is common in patients with diabetes mellitus. The aim of this study is to identify the effect of two different physical training programs, using ultrasound techniques, on the endothelial function of patients with type 2 DM.
Subjects Subjects with type 2 DM, of both genders, aged between 40 and 65 years, without
coronary artery disease, characterized by a negative maximum exercise test, will be studied.
This study will be carried out at the Prevention and Cardiovascular Rehabilitation Unit
Unicardio, in Hospital Santa Catarina, in the city of Blumenau, State of Santa Catarina,
South of Brazil. The patients will be invited to participate in the study as they are
treated at the clinic during regular medical consultations, with approximately 235 patients
per month. After that, patient randomization will be carried out, by dividing the patients
in the groups: intervention (a group undergoing high-intensity exercise and another one
undergoing low-intensity exercise) and control group (patients not submitted to the physical
exercise program, but went to the health care center to undergo blood pressure and heart
rate measurement).
The following exclusion criteria will be used: subjects in whom, for reasons related to
clinical screening, it is not possible to withdrawn medications with known endothelial
function effect, such as angiotensin-converting enzyme inhibitors, calcium channel blockers,
nitrates, beta-blockers, anti-oxidizers, hormonal replacement therapy, insulin; subjects
with altered maximum exercise test (positive); cigarette smoking history in the last 12
months; participation in a physical exercise program in the last 12 months; chronic
obstructive pulmonary disease; high blood pressure levels (systolic blood pressure > 180mmHg
and diastolic blood pressure > 110mmHg); osteoporosis and diabetic neuropathy.
The study protocol is in accordance with the Declaration of Helsinki. All participants will
be informed of the objectives of the study and possible risks and discomforts involved with
their participation in the experiments, and will be included only after signing the informed
consent term. The study protocol was approved by the Ethics Committee of Hospital Santa
Catarina (Blumenau, Santa Catarina, Brazil).
Study Protocol All study subjects will undergo an initial clinical examination performed by
a cardiologist. Before and after 6 weeks of intervention, the patients will undergo the
maximum exercise test, physical examination and endothelial function evaluation. The
participants will be submitted to a program of physical exercise in the Prevention and
Cardiovascular Rehabilitation Unit Unicardio of Hospital Santa Catarina, in Blumenau,
Brazil. After the maximum exercise test is limited by fatigue, the participants will be
referred, based on their individual exercise prescription and randomized to a low (50 to 60%
of maximum heart rate) or high intensity (75 to 85% of maximum heart rate) exercise program.
During the study period, the patients should maintain the same doses of medications.
All patients will undergo a non-invasive evaluation of endothelial function, performed at
Clínica Uniangio, in the city of Blumenau, Brazil. Two investigators will perform all the
tests, while blinded to the group the patients were randomized to. All patients will undergo
an 8-12 hour period of food and water deprivation. The individuals will be placed in the
supine position, with the arms placed along the body in a comfortable position to obtain
image of the brachial artery, above the antecubital fossa, in the longitudinal plane.
An ultrasonic sound wave equipment will be used (Acuson, Model 128XP System, Mountain View,
California, USA), with vascular software for two-dimensional images (2D), color Doppler with
an internal electrocardiogram (ECG) monitor and a high-frequency vascular transducer
(Acuson, Model L7 7,5-10 MHz, Mountain View, California, USA). After positioned, a segment
with anterior and posterior interfaces with the arterial wall will be selected for 2D
images. Arterial diameter values will be recorded in super-VHS for subsequent analysis.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |